A
Arthur W. Baker
Researcher at Duke University
Publications - 60
Citations - 973
Arthur W. Baker is an academic researcher from Duke University. The author has contributed to research in topics: Medicine & Mycobacterium abscessus. The author has an hindex of 12, co-authored 50 publications receiving 539 citations. Previous affiliations of Arthur W. Baker include University of Virginia Health System & Durham University.
Papers
More filters
Journal ArticleDOI
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
Cathrine Axfors,Cathrine Axfors,Andreas M. Schmitt,Andreas M. Schmitt,Perrine Janiaud,Janneke van’t Hooft,Janneke van’t Hooft,Sherief Abd-Elsalam,Ehab F. Abdo,Benjamin S. Abella,Javed Akram,Ravi K. Amaravadi,Derek C. Angus,Yaseen M. Arabi,Shehnoor Azhar,Lindsey R. Baden,Arthur W. Baker,Leila Belkhir,Thomas Benfield,Marvin A.H. Berrevoets,Cheng-Pin Chen,Tsung-Chia Chen,Shu-Hsing Cheng,Chien-Yu Cheng,Wei-Sheng Chung,Yehuda Z. Cohen,Lisa N. Cowan,Olav Dalgard,Olav Dalgard,Fernando Val,Marcus V. G. Lacerda,Gisely Cardoso de Melo,Lennie P. G. Derde,Vincent Dubée,Anissa Elfakir,Anthony C. Gordon,Carmen M. Hernández-Cárdenas,Thomas Hills,Thomas Hills,Andy I. M. Hoepelman,Yi-Wen Huang,Bruno Igau,Ronghua Jin,Felipe Jurado-Camacho,Khalid S. Khan,Peter G. Kremsner,Benno Kreuels,Benno Kreuels,Cheng-Yu Kuo,Thuy Le,Yi-Chun Lin,Wu-Pu Lin,Tse-Hung Lin,Magnus Nakrem Lyngbakken,Magnus Nakrem Lyngbakken,Colin McArthur,Colin McArthur,Colin McArthur,Bryan J. McVerry,Patricia Meza-Meneses,Wuelton Marcelo Monteiro,Susan C. Morpeth,Ahmad Mourad,Mark J. Mulligan,Srinivas Murthy,Susanna Naggie,Shanti Narayanasamy,Alistair Nichol,Lewis A. Novack,Sean M. O'Brien,Nwora Lance Okeke,Léna Perez,Rogelio Perez-Padilla,Laurent Perrin,Arantxa Remigio-Luna,Norma E. Rivera-Martinez,Frank W. Rockhold,Sebastian Rodriguez-Llamazares,Robert Rolfe,Rossana Rosa,Helge Røsjø,Helge Røsjø,Vanderson de Souza Sampaio,Todd B. Seto,Todd B. Seto,Muhammad Shahzad,Shaimaa Soliman,Jason E. Stout,Ireri Thirion-Romero,Andrea B. Troxel,Ting-Yu Tseng,Nicholas A Turner,Robert J. Ulrich,Stephen R. Walsh,Steve Webb,Steve Webb,Jesper M. Weehuizen,Maria Velinova,Hon-Lai Wong,Rebekah Wrenn,Fernando G. Zampieri,Wu Zhong,David Moher,Steven N. Goodman,John P. A. Ioannidis,Lars G. Hemkens,Lars G. Hemkens +106 more
TL;DR: In this article, a rapid meta-analysis of ongoing, completed, or discontinued RCTs on hydroxychloroquine or chloroquine treatment for any COVID-19 patients was presented.
Posted ContentDOI
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials
Cathrine Axfors,Cathrine Axfors,Andreas M. Schmitt,Andreas M. Schmitt,Perrine Janiaud,Janneke van 't Hooft,Sherief Abd-Elsalam,Ehab F. Abdo,Benjamin S. Abella,Javed Akram,Ravi K. Amaravadi,Derek C. Angus,Yaseen M. Arabi,Shehnoor Azhar,Lindsey R. Baden,Arthur W. Baker,Leila Belkhir,Thomas Benfield,Marvin A.H. Berrevoets,Cheng-Pin Chen,Tsung-Chia Chen,Shu-Hsing Cheng,Chien-Yu Cheng,Wei-Sheng Chung,Yehuda Z. Cohen,Lisa N. Cowan,Olav Dalgard,Olav Dalgard,Fernando Almeida Val,Marcus V. G. Lacerda,Gisely Cardoso de Melo,Lennie P. G. Derde,Vincent Dubée,Anissa Elfakir,Anthony C. Gordon,Carmen M. Hernández-Cárdenas,Thomas Hills,Andy I. M. Hoepelman,Yi-Wen Huang,Bruno Igau,Ronghua Jin,Felipe Jurado-Camacho,Khalid S. Khan,Peter G. Kremsner,Benno Kreuels,Benno Kreuels,Cheng-Yu Kuo,Thuy Le,Yi-Chun Lin,Wu-Pu Lin,Tse-Hung Lin,Magnus Nakrem Lyngbakken,Magnus Nakrem Lyngbakken,Colin McArthur,Bryan J. McVerry,Patricia Meza-Meneses,Wuelton Marcelo Monteiro,Susan C. Morpeth,Ahmad Mourad,Mark J. Mulligan,Srinivas Murthy,Susanna Naggie,Shanti Narayanasamy,Alistair Nichol,Lewis A. Novack,Sean M. O'Brien,Nwora Lance Okeke,Léna Perez,Rogelio Perez-Padilla,Laurent Perrin,Arantxa Remigio-Luna,Norma E. Rivera-Martinez,Frank W. Rockhold,Sebastian Rodriguez-Llamazares,Robert Rolfe,Rossana Rosa,Helge Røsjø,Helge Røsjø,Vanderson de Souza Sampaio,Todd B. Seto,Todd B. Seto,Muhammad Shehzad,Shaimaa Soliman,Jason E. Stout,Ireri Thirion-Romero,Andrea B. Troxel,Ting-Yu Tseng,Nicholas A Turner,Robert J. Ulrich,Stephen R. Walsh,Steve Webb,Jesper M. Weehuizen,Maria Velinova,Hon-Lai Wong,Rebekah Wrenn,Fernando G. Zampieri,Wu Zhong,David Moher,Steven N. Goodman,John P. A. Ioannidis,Lars G. Hemkens,Lars G. Hemkens +101 more
TL;DR: It is found that there is no benefit of hydroxychloroquine or chloroquine on the survival of COVID-19 patients, and the confidence interval is compatible with increased mortality or negligibly reduced mortality.
Journal ArticleDOI
Two-Phase Hospital-Associated Outbreak of Mycobacterium abscessus: Investigation and Mitigation.
Arthur W. Baker,Sarah S. Lewis,Barbara D. Alexander,Luke F. Chen,Richard J. Wallace,Barbara A. Brown-Elliott,Pamela J. Isaacs,Lisa C. Pickett,Chetan B. Patel,Peter K. Smith,John Reynolds,Jill Engel,Cameron R. Wolfe,Carmelo A. Milano,Jacob N. Schroder,Robert D. Davis,Matthew G. Hartwig,Jason E. Stout,Nancy Strittholt,Eileen K Maziarz,Jennifer Horan Saullo,Kevin C. Hazen,Richard J. Walczak,Ravikiran Vasireddy,Sruthi Vasireddy,Celeste M. McKnight,Deverick J. Anderson,Daniel J. Sexton +27 more
TL;DR: Healthcare facilities with endemic NTM should consider similar tap water avoidance and engineering strategies to decrease risk of NTM infection and investigate and mitigated a 2-phase clonal outbreak of M. abscessus linked to hospital tap water.
Journal ArticleDOI
Invasive Fungal Infection After Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis
Arthur W. Baker,Arthur W. Baker,Eileen K Maziarz,Christopher Arnold,Melissa D. Johnson,Melissa D. Johnson,Adrienne D Workman,John Reynolds,John R. Perfect,Barbara D. Alexander +9 more
TL;DR: Benefit is suggested in providing systemic antifungal prophylaxis targeting Candida for up to 90 days after transplant and extending mold-active prophYLaxis forUp to 180 days after surgery.
Journal ArticleDOI
Use of Letermovir as Salvage Therapy for Drug-Resistant Cytomegalovirus Retinitis.
Nicholas A Turner,Andrew Strand,Andrew Strand,Dilraj S. Grewal,Gary M. Cox,Sana Arif,Arthur W. Baker,Arthur W. Baker,Eileen K Maziarz,Jennifer Horan Saullo,Cameron R. Wolfe +10 more
TL;DR: Letermovir is used for salvage treatment in four solid organ transplant recipients with ganciclovir-resistant CMV retinitis, but three patients failed to maintain virologic suppression, including two patients who developed genotypically confirmed resistance to letermovir while on therapy.